Principal Financial Group Inc. Increases Stock Holdings in Henry Schein, Inc. $HSIC

Principal Financial Group Inc. raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 7.1% in the first quarter, HoldingsChannel reports. The firm owned 122,845 shares of the company’s stock after buying an additional 8,196 shares during the quarter. Principal Financial Group Inc.’s holdings in Henry Schein were worth $9,054,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Assenagon Asset Management S.A. raised its position in Henry Schein by 212.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 67,181 shares of the company’s stock worth $5,078,000 after acquiring an additional 45,701 shares during the period. Tudor Investment Corp ET AL purchased a new position in shares of Henry Schein during the 3rd quarter worth $15,375,000. Heartland Advisors Inc. bought a new stake in shares of Henry Schein during the 4th quarter valued at $9,070,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Henry Schein by 15.8% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 115,279 shares of the company’s stock valued at $8,856,000 after acquiring an additional 15,765 shares during the period. Finally, Jefferies Financial Group Inc. increased its stake in shares of Henry Schein by 365.6% in the 4th quarter. Jefferies Financial Group Inc. now owns 41,903 shares of the company’s stock worth $3,167,000 after purchasing an additional 32,903 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $85.47 on Monday. The firm has a fifty day moving average price of $80.98 and a 200-day moving average price of $78.03. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.36 and a quick ratio of 0.75. The stock has a market cap of $9.74 billion, a PE ratio of 25.82, a price-to-earnings-growth ratio of 1.65 and a beta of 0.81. Henry Schein, Inc. has a 1 year low of $61.94 and a 1 year high of $89.34.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The company had revenue of $3.37 billion for the quarter, compared to analysts’ expectations of $3.34 billion. During the same quarter in the previous year, the company earned $1.15 EPS. Henry Schein’s revenue for the quarter was up 6.3% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 5.32 earnings per share for the current fiscal year.

Insider Transactions at Henry Schein

In other Henry Schein news, Director William K. Daniel purchased 10,000 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $69.19 per share, with a total value of $691,900.00. Following the completion of the acquisition, the director directly owned 20,000 shares in the company, valued at $1,383,800. The trade was a 100.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.89% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on HSIC. Robert W. Baird set a $97.00 target price on Henry Schein in a report on Wednesday, May 6th. UBS Group reissued a “neutral” rating and set a $85.00 price target (down from $87.00) on shares of Henry Schein in a report on Wednesday, May 6th. Wall Street Zen cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. BMO Capital Markets assumed coverage on Henry Schein in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $85.00 price objective on the stock. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Henry Schein in a research note on Monday, May 4th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $88.62.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.